The V-Go ® is a simple, fully disposable device for the delivery of basal-bolus insulin therapy in adults with Type 2 diabetes. The V-Go provides a continuous preset basal rate of insulin and allows ...

BRIDGEWATER, N.J., May 18, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers V-Go® Wearable Insulin Delivery device, a simple, all-in-one ...

Afrezza revenue rose 23% to $18.49 million in the three months through the end of September, owing to higher prices and ...

In older adults with type 2 diabetes, use of human regular insulin delivered by V-Go ® demonstrated similar glycemic control with no increased hypoglycemia risk compared to use of rapid acting insulin ...

BRIDGEWATER, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device, announced today it ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has approved an expanded indication for the ...

“Our members count on Sam’s Club for both quality care and convenience,” said Matt Holt, Vice President at Sam’s Club, in a statement to Progressive Grocer. “Expanding same-day delivery to include ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

A new automated insulin pump designed by Deka Research & Development and powered by Tidepool’s data and dosing platform has cleared the FDA and is now on its way to support children and adults with ...

This could be used to deliver medicine during natural disasters and more. An international team of scientists and health care workers have completed the world's first drone insulin delivery -- ...